First-generation and preclinical evaluation of an EphA5-targeted antibody-drug conjugate in solid tumors

Journal:

Journal of Clinical Investigation

Published:

2025-07-15

DOI:

10.1172/jci188492

Affiliations:

4

Authors:

14

Go to article

Institutions	Authors	Share
MBrace Therapeutics, Inc., United States of America (USA)	8.000000	0.57
Rutgers Cancer Institute of New Jersey (CINJ), United States of America (USA)	3.000000	0.21
Rutgers, The State University of New Jersey (RU), United States of America (USA)	3.000000	0.21

Interested in Oncology and Carcinogenesis?